Clinical Trial Update: Erlotinib Concurrent With Radiation Therapy in Non-small-cell Lung Cancer [Phase 2]

View source ↗

Summary

This document provides an update on a Phase 2 clinical trial evaluating erlotinib concurrently with radiation therapy in non-small cell lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Tarceva (erlotinib)

Snippet

Sponsor: Tianjin Medical University Cancer Institute and Hospital | Conditions: Carcinoma, Non-Small Cell Lung | Phase 2 | Status: UNKNOWN